第143回 アイセムスセミナー: 坂田 恒昭 博士、Sotirios Karathanasis 博士、Stephen Minger 博士
坂田 恒昭 博士
Shionogi Science Program: an industry-academic initiative for open innovation in pharmaceutical industry
Shionogi has a long history of building partnerships and collaborating with researchers in areas of interest and unmet medical need. As part of this wider goal, the Shionogi Science Program (SSP) was launched in the UK in 2011 following the success of the Japanese initiative FINDS (PHarma-INnovation Discovery competition Shionogi) which was founded in 2007.
Sotirios Karathanasis 博士
Industry-Academia Collaborations: Current Trends and Issues to Overcome
Although a variety of factors contribute to the productivity decline of the Pharmaceutical Industry (Pharma) in recent years, the declining ability to innovate is thought to play a fundamental role. This, so called "innovation deficit", occurs in the background of an accelerated pace of innovation in Academia. Dr. Karathanasis will discuss possible factors responsible for this "innovation deficit" in Pharma, focusing on elements that might prevent Academic innovations from effective translocation, internalization, and translation into new drug Discovery and Development projects in Pharma. Finally, he will overview current models for Industry-Academia collaborations and discuss issues to overcome.
Stephen Minger 博士
Innovating Preclinical Drug Development & Human Cell Therapy
The isolation of tissue-specific, multipotent stem cells from adult organs and the derivation of pluripotent human embryonic stem cells offer the potential for regeneration of a number of different tissues and organs susceptible to age-related degenerative conditions and traumatic injury. In the not-too-distant future, it will be possible to repair heart tissue damaged by myocardial infarction, to replace neuronal cells lost in Parkinson's and Alzheimer's diseases, to transplant new insulin producing cells for diabetics and myelinating cells for individuals afflicted with multiple sclerosis, and to replace bone and cartilage lost through aging and inflammatory disease.
| 講演者 | 坂田 恒昭 博士 塩野義製薬株式会社 グローバルデベロプメントオフィス イノベーションデザイン部門長 Sotirios Karathanasis 博士 Executive Director, Strategy and Externalization Cardiovascular and Gastrointestinal Research Area アストラゼネカ Stephen Minger 博士 Chief Scientist, Cellular Sciences, Life Sciences, GE Healthcare |
|---|---|
| 日時 | 2013年10月24日（木）10:00-12:00 |
| 場所 | 京都大学 iCeMSコンプレックス1 本館 2階 セミナールーム (A207) アクセスマップ |
| フライヤー |  PDF (185KB) |
| 主催 | 京都大学 物質－細胞統合システム拠点（iCeMS＝アイセムス） |
| 共催 | NPO京都SMI |
| 事前予約 |  専用ウェブサイト申し込み締め切り：10月15日（火） |
| 連絡先 | 浅田 孝 | tasada@icems.kyoto-u.ac.jp |